IRISanRaf

PICCONI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.526
AS - Asia 2.224
EU - Europa 600
SA - Sud America 235
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 44
OC - Oceania 15
Totale 6.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.107
TR - Turchia 945
CN - Cina 558
SG - Singapore 499
CA - Canada 398
BR - Brasile 206
IT - Italia 154
CZ - Repubblica Ceca 119
DE - Germania 87
EU - Europa 67
GB - Regno Unito 67
VN - Vietnam 58
IE - Irlanda 45
IN - India 39
HK - Hong Kong 28
BD - Bangladesh 20
FI - Finlandia 18
JP - Giappone 18
ZA - Sudafrica 18
RU - Federazione Russa 17
MX - Messico 15
FR - Francia 13
NL - Olanda 13
ES - Italia 12
UA - Ucraina 12
RO - Romania 10
ID - Indonesia 9
AU - Australia 8
EC - Ecuador 7
SE - Svezia 7
AR - Argentina 6
CO - Colombia 6
DK - Danimarca 6
NZ - Nuova Zelanda 6
SC - Seychelles 6
TW - Taiwan 6
EG - Egitto 5
PK - Pakistan 5
JO - Giordania 4
KR - Corea 4
MA - Marocco 4
PL - Polonia 4
PS - Palestinian Territory 4
BE - Belgio 3
CL - Cile 3
IL - Israele 3
KE - Kenya 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
GR - Grecia 2
IQ - Iraq 2
IR - Iran 2
LK - Sri Lanka 2
LT - Lituania 2
NG - Nigeria 2
NI - Nicaragua 2
PE - Perù 2
PH - Filippine 2
SN - Senegal 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
DJ - Gibuti 1
DZ - Algeria 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
LB - Libano 1
LY - Libia 1
MN - Mongolia 1
MR - Mauritania 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
TJ - Tagikistan 1
WS - Samoa 1
Totale 6.711
Salva come PNG Salva come JPEG
Città #
Kocaeli 807
San Mateo 688
Toronto 373
Dallas 277
Wilmington 202
Houston 181
Singapore 163
Chandler 159
Santa Clara 159
Lawrence 139
Princeton 139
Ashburn 135
Olomouc 119
Beijing 115
Fairfield 84
Shanghai 59
Seattle 50
Woodbridge 48
Los Angeles 42
Guangzhou 37
Munich 35
Redwood City 34
Hong Kong 28
The Dalles 25
São Paulo 24
Dublin 23
Shenzhen 23
Cambridge 22
Brooklyn 21
Columbus 21
Rome 20
Chicago 19
Falls Church 19
New York 19
Hanoi 17
Ho Chi Minh City 16
Jiaxing 15
Tokyo 15
Helsinki 13
Johannesburg 13
Frankfurt am Main 12
London 11
Wuhan 11
Chennai 10
Constanta 10
Pune 10
Belo Horizonte 9
Boston 9
Council Bluffs 9
Mexico City 8
Montreal 7
Rui'an 7
Stockholm 7
Charlotte 6
Dongyang 6
Wuxi 6
Bristol 5
Dhaka 5
Guayaquil 5
Haining 5
Jakarta 5
Padova 5
Phoenix 5
Rio de Janeiro 5
Saint Louis 5
Washington 5
Amman 4
Ankara 4
Atlanta 4
Boardman 4
Espoo 4
Florence 4
Genoa 4
Nanjing 4
Quanzhou 4
Redmond 4
San Francisco 4
Shaoxing 4
Taipei 4
Trento 4
Warsaw 4
Xi'an 4
Amsterdam 3
Bismarck 3
Bogotá 3
Brasília 3
Buffalo 3
Cagliari 3
Curitiba 3
Franz Josef 3
Guarulhos 3
Haiphong 3
Hangzhou 3
Istanbul 3
Joinville 3
Juiz de Fora 3
Kunming 3
Kyiv 3
Madrid 3
Manaus 3
Totale 4.704
Salva come PNG Salva come JPEG
Nome #
Direct and indirect pathways of basal ganglia: a critical reappraisal 186
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 143
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation 96
Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease 89
Alpha-synuclein oligomers alter the spontaneous firing discharge of cultured midbrain neurons 87
Quantal release of dopamine and action potential firing detected in midbrain neurons by multifunctional diamond-based microarrays 80
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions. 77
Corrigendum: Alpha-synuclein oligomers alter the spontaneous firing discharge of cultured midbrain neurons 76
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 72
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease 72
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. 66
BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior 66
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuo-spatial memory alteration. 64
Dopamine drives binge-like consumption of a palatable food in experimental parkinsonism. 61
Synaptic dysfunction in Parkinson's disease 60
Motor Complications in Parkinson's Disease: Striatal Molecular and Electrophysiological Mechanisms of Dyskinesias 60
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. 60
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. 59
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 59
Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum 57
An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease 56
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 56
Theta-burst stimulation and striatal plasticity in experimental parkinsonism 55
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 55
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit 55
Corticostriatal synaptic plasticity alterations in the R6/1 transgenic mouse model of Huntington's disease 55
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 54
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. 54
NMDA receptor G1uN2D subunit participates to levodopa-induced dyskinesia pathophysiology 54
Dopaminergic control of synaptic plasticity in the dorsal striatum 53
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts 53
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap 53
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 53
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission 53
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. 52
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum. 52
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. 52
Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities 52
Acetyl-l-carnitine protects striatal neurons against in vitro ischemia: The role of endogenous acetylcholine 51
Interaction between basal ganglia and limbic circuits in learning and memory processes 51
Striatal spreading depolarization: possible implication in L-DOPA-induced dyskinetic like-behavior. 51
Early Synaptic Dysfunction in Parkinson's Disease: Insights From Animal Models 51
Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias 51
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias 50
Role of tonically-active neurons in the control of striatal function: Cellular mechanisms and behavioral correlates 50
Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate 1-DOPA-induced dyskinesia 50
N-Methyl-D-aspartate (NMDA) Receptor Composition Modulates Dendritic Spine Morphology in Striatal Medium Spiny Neurons 50
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D-2/A(2A) Receptor Interaction in the Striatum: Implications for Parkinson's Disease 50
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment 49
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia 48
Striatum-hippocampus balance: From physiological behavior to interneuronal pathology 48
New Synaptic and Molecular Targets for Neuroprotection in Parkinson's Disease 48
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 47
Tissue plasminogen activator is required for corticostriatal long-term potentiation 46
Rhes-mTORC1 interaction: A new possible therapeutic target in Parkinson's disease and L-dopa-induced dyskinesia? 46
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? 46
Mechanisms underlying dopaminergic control of cortico-striatal synaptic transmission 46
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. 46
Mechanisms underlying altered striatal synaptic plasticity in old A53T-alpha synuclein overexpressing mice 46
Memantine alters striatal plasticity inducing a shift of synaptic responses toward long-term depression 46
Neural networks and synaptic plasticity in Parkinson's disease: beyond motor deficits 46
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors 46
Protein phosphatase inhibitors induce modification of synapse structure and tau hyperphosphorylation in cultured rat hippocampal neurons 46
Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. 46
Prenatal stress and hippocampal BDNF expression: a fading imperative 46
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 46
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 45
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice 44
Dopamine denervation induces neurotensin immunoreactivity in GABA-parvalbumin striatal neurons 44
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum 44
Transcranial Magnetic Stimulation Exerts "Rejuvenation" Effects on Corticostriatal Synapses after Partial Dopamine Depletion 44
NR2B subunit exerts a critical role in postischemic synaptic plasticity. 43
Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia 43
Dopamine-mediated regulation of corticostriatal synaptic plasticity. 43
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia 43
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTP 43
Stimulation of D1/PKA/DARPP-32/PP-1 pathway is required for corticostriatal LTD and LTP 43
Unilateral dopamine denervation blocks corticostriatal LTP 42
Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease 42
Targeting Metabotropic Glutamate Receptors as a New Strategy Against Levodopa-Induced Dyskinesia in Parkinson's Disease? 42
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 42
Serotonin drives striatal synaptic plasticity in a sex-related manner 42
Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression. 41
FUNCTIONAL INTERACTIONS WITHIN STRIATAL MICROCIRCUIT IN ANIMAL MODELS OF HUNTINGTON'S DISEASE 41
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 41
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 41
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia 41
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia 41
NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients 41
Molecular mechanisms underlying levodopa-induced dyskinesia. 41
Plastic abnormalities in experimental Huntington's disease 41
Hyperkinetic disorders and loss of synaptic downscaling 41
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. 41
Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons 40
L-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via beta-adrenergic receptors 40
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. 40
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 40
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment 40
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid 40
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 40
Totale 5.320
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.787
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.787
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.182 0 0 0 11 44 92 70 22 35 48 807 53
2021/20221.349 11 369 372 1 9 12 89 139 36 279 11 21
2022/2023647 308 15 13 54 33 16 5 21 29 63 82 8
2023/2024571 0 2 17 127 26 17 15 37 3 21 70 236
2024/20251.466 54 338 98 68 92 234 41 98 191 20 58 174
2025/2026942 258 244 298 142 0 0 0 0 0 0 0 0
Totale 6.961